Salute e Benessere

Implantica receives MDR certification for RefluxStop™

Implantica was granted the EU Quality Management System (QMS) certificate and the EU Technical Documentation Assessment Certificate confirming Implantica's QMS and the RefluxStop™ are compliant with the latest regulations and standards required for medical devices in Europe. Implantica was granted the EU Quality Management System (QMS) certificate and the EU Technical Documentation Assessment Certificate confirming Implantica's QMS and the RefluxStop™ are compliant with the latest regulations...
PR Newswire
07/09/2023

Chiesi Group: Climate Change Threatens Respiratory Patients' Quality of Life…

Delving into the experiences of people with lung diseases in five key countries (UK, Italy, Spain, Germany, and France), the report suggests that climate-related factors have a significant impact on their quality of life, stretching beyond physical health. It also explores how this impact may interact with other social determinants such as education, income, and overall socio-economic status, and calls for holistic health policy solutions. Delving into the experiences of people with lung...
PR Newswire
07/09/2023

Eminence Opens New GMP Cell Culture Media Manufacturing Facility

Equipped with cutting-edge vertical pin-milling manufacturing technology and bolstered by world-class utility systems, the new facility adheres to international GMP standards, ISO9001, and ISO13485 regulations. It is designed to provide biopharmaceutical companies worldwide with consistently high-quality, batch-to-batch stable cell culture media products. Equipped with cutting-edge vertical pin-milling manufacturing technology and bolstered by world-class utility systems, the new facility...
PR Newswire
07/09/2023

Valneva and Pfizer Report Positive Pediatric and Adolescent Phase 2 Booster…

Strong immune responseshown in both children and adolescents one month after booster dose (month 19) in VLA15-221 studyPreviously observed high anamnestic antibody response in adults confirmedVLA15 well-tolerated in all age groups following booster doseSaint-Herblain (France) & New York , September 7, 2023–Valneva SE(Nasdaq: VALN; Euronext Paris: VLA) andPfizer Inc.(NYSE: PFE) announced today positive pediatric and adolescent...
Nasdaq GlobeNewswire
07/09/2023

Santhera Announces Half-Year 2023 Financial Results and Provides Corporate…

Ad hoc announcement pursuant to Art. 53 LR A conference call will be held today at 14:30 CEST / 13:30 BST / 08:30 EDT . Details are at the end of this news release .Revenue from contracts with customers of CHF 3.9 million (H1-2022: CHF 6.3 million)Operating result of CHF -20.3 million (H1-2022: CHF -25.5 million) and net result of CHF -23.3 million (H1-2022: CHF -29.7 million)Review of vamorolone's regulatory filings (NDA, MAA) for Duchenne muscular dystrophy (DMD)...
Nasdaq GlobeNewswire
07/09/2023

Vivoryon Therapeutics N.V. Reports H1 2023 Financial Results and Highlights…

Vivoryon Therapeutics N.V. Reports H1 2023 Financial Results and Highlights Operational Progress Both VIVIAD and VIVA-MIND studies on track; final data from VIVIAD expected in Q1/2024 , and a studyupdate on VIVA-MIND expected in Q4/2023Varoglutamstat demonstrates veryencouraging safety data with no drug-related ARIAs at therapeutic dose of 600 mg twice daily, a dose demonstrated to result in nearly 90% target occupancyDSMB meeting...
Nasdaq GlobeNewswire
07/09/2023

BioSenic reports half year 2023 results

REGULATED INFORMATIONThe interim financial report is prepared in accordance with article 13 of the Royal Decree on the obligations of issuers of financial instruments admitted to trading on a regulated market and can be accessed on the website of Biosenic in the section 'Financial reports'. BioSenic publishes its interim financial report in English. A French translation of the report will also be made available. In the event of differences between the English and the French version of the...
Nasdaq GlobeNewswire
07/09/2023

Performance Health Announces Acquisition of Sissel France

"The acquisition of Sissel marks a strategic expansion of our product offerings in France and signifies the growth of our family of brands. It cements our presence in the industry, broadening our customer base and market reach," said Greg Nulty, Chief Executive Officer. "Combining the strengths of Performance Health and Sissel France, unlocks growth opportunities, building upon the solid foundation of Performance Health's existing business in France." "The acquisition of…
PR Newswire
07/09/2023

Triple-Negative Breast Cancer Market to Accelerate Substantially During the…

Key Takeaways from the Triple-Negative Breast Cancer Market Report Key Takeaways from the Triple-Negative Breast Cancer Market Report Discover which therapies are expected to grab the major triple-negative breast cancer market share @Triple-Negative Breast Cancer Market Report Triple-Negative Breast Cancer Overview Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by the absence of three key receptors: estrogen receptors (ER), progesterone...
PR Newswire
06/09/2023

Hyloris Pharmaceuticals Reports 2023 Half-Year Results and provides Business…

Total revenue and other income nearly doubled (€2,4 million, +95%)R&D progress across the board, including initiation of the 4-arm Phase 2 clinical trial for Alenura TM, targeting IC/BPS, a condition affecting at least 6 million U.S. patientsPDUFA goal date for Maxigesic® IV set for 17 October 2023 by the U.S. FDA 1 Evaluating external product candidates & advancing internal projects to reach 30 key assets before 2025Multiple NDA 2submissions expected within the next 18...
Nasdaq GlobeNewswire
06/09/2023

MYRA VISION ANNOUNCES SUCCESSFUL FIRST-IN-HUMAN USE OF ITS CALIBREYE™ SYSTEM, A…

The Calibreye System is engineered to put outflow control in the hands of glaucoma specialists, giving them the opportunity to provide personalized therapy while minimizing complications. Once implanted, the Calibreye shunt is designed to allow non-invasive in-office increases or decreases in outflow as a patient's individual treatment needs change. The Calibreye System is engineered to put outflow control in the hands of glaucoma specialists, giving them the opportunity to provide…
PR Newswire
06/09/2023

Medical Equipment Top Trending Markets - By The Business Research Company

In this dynamic environment, The Business Research Company (TBRC) offers invaluable insights and analysis through their reports in the medical equipment market. These reports empower businesses to stay informed about market trends, competitive dynamics, and emerging opportunities. In this dynamic environment, The Business Research Company (TBRC) offers invaluable insights and analysis through their reports in the medical equipment market. These reports empower businesses to stay informed…
PR Newswire
06/09/2023

Precision Medicine Market worth $50.2 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=215185595 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=215185595 Browse in-depth TOC on "Precision Medicine Market" 189 - Tables 50 - Figures 240 - Pages Precision Medicine Market Scope: Hospitals and Clinics subsegment accounted is the fastest growing of the precision medicine market by product & service Among the...
PR Newswire
06/09/2023

Epidemiology Study of Lung Cancer with Diagnosis and Treatment Analysis with…

Lung cancer, a formidable adversary, ranks among the leading causes of cancer-related deaths worldwide. The battle against this disease has been relentless, demanding innovative approaches to enhance early diagnosis and effective treatment. Lung cancer, a formidable adversary, ranks among the leading causes of cancer-related deaths worldwide. The battle against this disease has been relentless, demanding innovative approaches to enhance early diagnosis and effective treatment. Exploring the...
PR Newswire
06/09/2023

SIFI ANNOUNCES CERTIFICATION OF WELL FUSION® ACCORDING TO EU MDR

MINI WELL and MINI WELL PROXA are intended for primary implantation for visual correction of aphakia in adult patients (> 18 years old) with or without presbyopia after removal of a cataractous lens and of aphakia after refractive lensectomy in presbyopic adults who desire spectacle independence for distance, intermediate and near vision. MINI WELL and MINI WELL PROXA are intended for primary implantation for visual correction of aphakia in adult patients (> 18 years old) with or…
PR Newswire
06/09/2023

The quantum computing in drug discovery services market is anticipated to grow…

Owing to the various benefits of quantum computing, such as big data processing and complex molecular modeling for minimizing cost and time investment, the adoption rate of quantum computing in pharmaceutical industry is expected to increase rapidly during the forecast period. Additionally, various partnerships have been inked for application of quantum computing in drug discovery. Majority of these partnerships are research and development agreements, followed by platform utilization…
PR Newswire
06/09/2023

Strategic Insights in Monkeypox with Comprehensive Epidemiology Study & Pipeline…

Diagnostic Analysis Diagnostic Analysis People often have numerous questions about this disease such as: "Can I get monkeypox if I had chickenpox" or "does Monkeypox kill you" or "what are symptoms monkeypox virus." Accurate and timely diagnosis is pivotal in managing Monkeypox cases so as to understand virus that causes monkeypox and to know what are the effects of monkeypox. This analysis further aids in curbing its spread. Another easy way is to follow the CDC…
PR Newswire
06/09/2023

DentalMonitoring Promotes the Use of Data to Improve Quality and Efficiency in…

Orthodontists use DentalMonitoring's scalable remote monitoring solution to deliver a convenient, connected patient experience while elevating clinical practices. The AI-driven platform is available in over 40 countries and serves all patients and all treatment types. Orthodontists using the platform have access to a wealth of data on lead engagement, compliance, clinical operations, and efficiencies through DM Insights, the industry's first data and analytics tool. DM Insights...
PR Newswire
06/09/2023

Trading in GN Store Nord shares by board members, executives and associated…

GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN Store Nord and/or persons closely associated with them.Details of the person discharging managerial responsibilities/person closely associatedNameSøren JelertReason for the notificationPosition/statusChief Financial OfficerInitial...
Nasdaq GlobeNewswire
06/09/2023

Trading in GN Store Nord shares by board members, executives and associated…

GN Store Nord has received notification pursuant to article 19 of regulation (EU) no. 596/2014 of the below transactions related to shares in GN Store Nord made by persons discharging managerial responsibilities in GN Store Nord and/or persons closely associated with them.Details of the person discharging managerial responsibilities/person closely associatedNameJukka PertolaReason for the notificationPosition/statusChairman Of the BoardInitial...
Nasdaq GlobeNewswire
06/09/2023

ivWatch Continues UK Expansion with Signing of Exclusive Distributor, Healthcare…

The Healthcare 21 sales and clinical teams are technically savvy and are also experts who are deeply rooted in the infusion therapy space. The two companies will join forces to build on the region's momentum positively impacting clinician practice and improving patient outcomes. The Healthcare 21 sales and clinical teams are technically savvy and are also experts who are deeply rooted in the infusion therapy space. The two companies will join forces to build on the region's momentum…
PR Newswire
06/09/2023

Antion Announces Granting of Key Technology Patent in the United States

Novel patent solidifies Antion's position as an industry leader in multiplex engineering of cell and gene therapies Together with its founding IP (US 9,556,433), the newly granted patent solidifies Antion's protection over its uniquely optimized gene silencing technologies. These proprietary technologies allow for highly efficient, tunable and multiplex engineering of cell and gene therapy products. It also underscores Antion's dedication to progress and commitment to innovation in its...
Nasdaq GlobeNewswire
06/09/2023

Imaging Endpoints Appoints Manish Sharma, MD as Chief Scientific Officer

"Manish's extensive expertise and innovative approach align perfectly with our vision to 'Connect Imaging to the Cure,'" said Ronald Korn, MD, PhD, Chief Medical Officer and Founder of Imaging Endpoints. "His leadership in medical and regulatory strategy, including IND, NDA, ANDA, and 505(b)(2) submissions, will further enhance the depth and expertise of our blinded, independent, central review (BICR) services." "Manish's extensive expertise and innovative approach align…
PR Newswire
06/09/2023

CXV Global and Panacea Technologies Announce New Name

To see Catalyx's new brand and learn more about its solutions, visit www.catalyx.ai. To see Catalyx's new brand and learn more about its solutions, visitwww.catalyx.ai. "Our new name embodies our expertise in the science of operational processes. A play on the word, 'catalyst,' a substance that increases the rate of a chemical reaction, Catalyx represents our dedication to leveraging our speed and capabilities to maximize our customers' operational performance," said Pieter Krynauw…
PR Newswire
06/09/2023
Altri  Comunicati